GROUP HEALTH OF PUGET SOUND DRUG COSTS ARE 6% OF TOTAL CARE COST BUT HMO BEING "SQUEEZED" BY MARKETPLACE; OUTPATIENT SETTING DRUG COSTS $40.9 MIL.
Executive Summary
At Group Health Cooperative of Puget Sound, "drugs is the second largest line-item in each of our medical centers except for hospitals, and so there continues to be constant scrutiny of the cost of drugs," Director of Medication Use Management Bill Baluch said at the Drug Information Association's March 16-17 pharmaceutical outcomes research meeting in Vancouver. Although staff compensation is "by far" the largest expense, Baluch said drug costs represent about 6% of Group Health's total cost of care. He noted that "care and drug costs are now clearly inventoried."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth